Biomerica
BMRA
7 hedge funds and large institutions have $188K invested in Biomerica in 2017 Q3 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 2 reducing their positions, and 2 closing their positions.
0% more funds holding
Funds holding: 7 → 7 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
0.01% less ownership
Funds ownership: 0.11% → 0.1% (-0.01%)
6% less capital invested
Capital invested by funds: $199K → $188K (-$11K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$10.4K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$584 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$16.9K |
| 2 |
Morgan Stanley
New York
|
-$10K |
| 3 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$5.84K |
BMRA Hedge Fund Activity: Q3 2017 in Review
7 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Biomerica (BMRA) for Q3 2017, worth a combined $188K — down 5.5% from $199K a quarter earlier.
Fund positioning in BMRA was balanced in Q3 2017: 2 funds opened new positions, 2 closed out, 0 added to existing stakes and 2 trimmed.
The largest buyer was Bank of America, opening a new position worth an estimated $10.4K. The largest seller was Millennium Management, cutting an estimated $16.9K.
- 7 institutional investors held Biomerica (BMRA) as of Q3 2017, unchanged from Q2 2017.
- Funds reported $188K of Biomerica stock for Q3 2017, down 5.5% quarter-over-quarter.
- 2 funds opened new Biomerica positions in Q3 2017 and 2 closed out, a net change of 0 holders.
- The largest Biomerica buyer in Q3 2017 was Bank of America, an estimated $10.4K added.
- The largest Biomerica seller in Q3 2017 was Millennium Management, an estimated $16.9K sold.
Based on aggregated 13F filings for Q3 2017.